Literature DB >> 20619412

Predicting the risk of coronary heart disease. II: the role of novel molecular biomarkers and genetics in estimating risk, and the future of risk prediction.

T H S Dent1.   

Abstract

This is the second of two articles reviewing recent findings about the risk of coronary heart disease. This paper is concerned with novel molecular biomarkers, genetic markers of risk and the future of risk prediction.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20619412     DOI： 10.1016/j.atherosclerosis.2010.06.021

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


  8 in total

Review 1.  Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.

Authors:  Richard Kones
Journal:  Drug Des Devel Ther       Date:  2011-06-13       Impact factor: 4.162

2.  Relationship of Postpartum Levels of Cystatin and High-Sensitivity C-Reactive Protein and Duration of Lactation in Mothers with Previous Gestational Hypertension or Preeclampsia.

Authors:  Malamo E Countouris; Jill R Demirci; Arun Jeyabalan; Janet M Catov; Eleanor B Schwarz
Journal:  Breastfeed Med       Date:  2019-03-15       Impact factor: 1.817

3.  Heterogeneity in coronary heart disease risk.

Authors:  Cristoforo Simonetto; Susanne Rospleszcz; Jan Christian Kaiser; Kyoji Furukawa
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

4.  Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database.

Authors:  Julia Hippisley-Cox; Carol Coupland; John Robson; Peter Brindle
Journal:  BMJ       Date:  2010-12-09

5.  Association of C-reactive protein with cardiovascular disease mortality according to diabetes status: pooled analyses of 25,979 participants from four U.K. prospective cohort studies.

Authors:  Andre Pascal Kengne; G David Batty; Mark Hamer; Emmanuel Stamatakis; Sébastien Czernichow
Journal:  Diabetes Care       Date:  2011-12-30       Impact factor: 19.112

6.  The German National Cohort: aims, study design and organization.

Authors: 
Journal:  Eur J Epidemiol       Date:  2014-05-20       Impact factor: 8.082

7.  Genetic variant SLC2A2 [corrected] Is associated with risk of cardiovascular disease – assessing the individual and cumulative effect of 46 type 2 diabetes related genetic variants.

Authors:  Anders Borglykke; Niels Grarup; Thomas Sparsø; Allan Linneberg; Mogens Fenger; Jørgen Jeppesen; Torben Hansen; Oluf Pedersen; Torben Jørgensen
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

8.  Homocysteine is not a risk factor for subclinical coronary atherosclerosis in asymptomatic individuals.

Authors:  Sangwoo Park; Gyung-Min Park; Jinhee Ha; Young-Rak Cho; Jae-Hyung Roh; Eun Ji Park; Yujin Yang; Ki-Bum Won; Soe Hee Ann; Yong-Giun Kim; Shin-Jae Kim; Sang-Gon Lee; Dong Hyun Yang; Joon-Won Kang; Tae-Hwan Lim; Hong-Kyu Kim; Jaewon Choe; Seung-Whan Lee; Young-Hak Kim
Journal:  PLoS One       Date:  2020-04-08       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.